Long-term follow-up of ponatinib efficacy and safety in patients (PTS) with the T315I mutation in the phase 1 and phase 2 (PACE) trials Meeting Abstract

   


Authors: Baccarani, M.; Mauro, M. J.; Cortes, J. E.; Hochhaus, A.; Hughes, T. P.; Guilhot, F.; Deininger, M. W.; Kantarjian, H. M.; Shah, N. P.; Bixby, D.; Flinn, I. W.; Lustgarten, S.; Rivera, V. M.; Haluska, F. G.; Clackson, T.; Talpaz, M.
Abstract Title: Long-term follow-up of ponatinib efficacy and safety in patients (PTS) with the T315I mutation in the phase 1 and phase 2 (PACE) trials
Meeting Title: 20th Congress of the European Hematology Association (EHA)
Journal Title: Haematologica
Volume: 100
Issue: Suppl. 1
Meeting Dates: 2015 Jun 11-14
Meeting Location: Vienna, Austria
ISSN: 0390-6078
Publisher: Ferrata Storti Foundation  
Date Published: 2015-06-01
Start Page: 65
Language: English
ACCESSION: WOS:000361204901138
PROVIDER: wos
PMCID: PMC4480587
Notes: Meeting Abstract: P236 -- Source: Wos